Pembrolizumab as Second‐Line Therapy for Advanced Urothelial Carcinoma
暂无分享，去创建一个
S. Culine | M. Climent | T. Choueiri | D. Bajorin | C. Sternberg | J. Bellmunt | D. Petrylak | D. Quinn | N. Vogelzang | R. de Wit | D. Vaughn | L. Fong | A. Necchi | W. Gerritsen | Y. Fradet | Jae-Lyun Lee | H. Gurney | Yabing Mai | C. Poehlein | R. Perini | D. Petrylak